Trials / Conditions / Netherton Syndrome

Netherton Syndrome

20 registered clinical trials studyying Netherton Syndrome — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms: NCT07280091	Assistance Publique - Hôpitaux de Paris	—
Recruiting	Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome NCT06953466	Quoin Pharmaceuticals	Phase 2 / Phase 3
Terminated	Natural History of Netherton Syndrome NCT05902663	Boehringer Ingelheim	—
Recruiting	A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725 NCT06539507	BioCryst Pharmaceuticals	Phase 1
Recruiting	Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome NCT06137157	Azitra Inc.	Phase 1
Terminated	A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients Wit NCT05979831	Daiichi Sankyo	Phase 1 / Phase 2
Terminated	A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome NCT05856526	Boehringer Ingelheim	Phase 2 / Phase 3
Recruiting	Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome NCT05789056	Quoin Pharmaceuticals	Phase 2 / Phase 3
Completed	A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Heal NCT05583669	Daiichi Sankyo	Phase 1
Active Not Recruiting	Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome NCT05521438	Quoin Pharmaceuticals	Phase 2 / Phase 3
Completed	A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS NCT05388903	Daiichi Sankyo	Phase 1
Completed	A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome NCT05211830	Sixera Pharma	Phase 1 / Phase 2
Unknown	A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome NCT04244006	University Hospital, Toulouse	Phase 2 / Phase 3
Enrolling By Invitation	Defining the Skin and Blood Biomarkers of Ichthyosis NCT03417856	Northwestern University	—
Completed	The Efficacy and Safety of Secukinumab in Patients With Ichthyoses NCT03041038	Northwestern University	Phase 2
Completed	Natural History and Biological Study of Netherton Syndrome NCT02081313	Institut National de la Santé Et de la Recherche Médicale, France	N/A
Unknown	Gene Therapy for Netherton Syndrome NCT01545323	Great Ormond Street Hospital for Children NHS Foundation Trust	Phase 1
Completed	Clinical Trial Using Humira in Netherton Syndrome NCT02113904	Assistance Publique - Hôpitaux de Paris	Phase 2
Completed	A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Nether NCT01428297	Novartis Pharmaceuticals	Phase 1
Completed	Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome NCT00208026	Children's Hospital of Philadelphia	Phase 1 / Phase 2